The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2024Measurement of Phosphorylated Alpha-synuclein in Skin Biopsies as a Prospective Biomarker for Parkinson’s Disease
Study Rationale: Parkinson’s disease (PD) is associated with an accumulation of phosphorylated alpha-synuclein, and the amount of the protein increases as PD progresses. We have found that we can...
-
Research Grant, 2024Assessment of Longitudinal Imaging Using Radiolabeled AV-133 in Early and Prodromal Parkinson’s Disease
Study Rationale: The clinical phase of Parkinson’s disease (PD) is preceded by a prodromal phase of progressing neurodegeneration that can last many years. Imaging markers such as radiolabeled AV-133...
-
Research Grant, 2024Developing Community Health Worker Remote Training Modules on Research, Brain Health and Parkinson’s Disease
Study Rationale: Neurodegenerative diseases including Parkinson's disease (PD) disproportionately impact underserved communities due to barriers in research participation and awareness. Community...
-
Freezing of Gait, 2024Use of Soft Robotic Apparel to Prevent Freezing of Gait in Parkinson’s Disease
Study Rationale: Freezing of gait (FoG) is a disabling walking problem that leads to loss of mobility, falling and poor quality of life in many people with Parkinson’s disease (PD). People with FoG...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2024Development of Selective Ion Channel Inhibitors as a Disease-modifying Therapy for Parkinson’s Disease
Study Rationale: Our aim is to develop an oral medication that will protect the dopamine neurons whose loss is thought to be the cause Parkinson’s disease (PD). Evidence suggests that excessive levels...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2024Examining the Effects of MTX325 on Mitochondrial Quality Control and the Prevention of Parkinson’s Disease Progression
Study Rationale: Mitochondria generate the energy needed for cells to work properly, and impaired mitochondrial function has been linked to the loss of dopamine neurons in multiple forms of Parkinson...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.